XF Drug Platform

Small molecule drug platform rapidly bactericidal with unique mechanisms of action

A platform of porphyrin molecules with antimicrobial activity intended for topical application for the treatment or prevention of infection

The XF drug platform has a novel, ultra-rapid mechanism that reduces the chance of bacteria becoming resistant to its action.

  • Infection prevention
  • Antimicrobial compounds
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Development
  • Research
  • Validation
  • Market entry
  • Marketed product

  • Company
  • Academia
  • Institute
  • NGO
  • Government

  • Yes
  • License
  • Co-develop
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:

    Infectious disease area:

      Geographic origin:

        Co-development, licensing, and outsourcing are all parts of the Destiny pharma business model.

        Destiny Pharma plc is a clinical stage, virtual biotech company


        What is going on with AMR?
        Stay tuned with remarkable global AMR news and developments!